Literature DB >> 25449490

Impact of the oral adsorbent AST-120 on oxidative stress and uremic toxins in high-risk chronic kidney disease patients.

Shigeru Toyoda1, Migaku Kikuchi1, Takaaki Komatsu2, Yuichi Hori2, Shiro Nakahara2, Sayuki Kobayashi2, Yoshihiko Sakai2, Teruo Inoue1, Isao Taguchi3.   

Abstract

Entities:  

Keywords:  AST-120; Chronic kidney disease; High risk patients; Oxidative stress; Uremic toxins

Mesh：

Substances：

Year:  2014        PMID： 25449490     DOI： 10.1016/j.ijcard.2014.09.196

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Antioxidative effect of an oral adsorbent, AST-120, and long-term outcomes in chronic kidney disease patients with cardiovascular disease.

Authors:  Shigeru Toyoda; Ryota Hashimoto; Taiyo Tezuka; Masashi Sakuma; Shichiro Abe; Tetsuya Ishikawa; Isao Taguchi; Teruo Inoue
Journal:  Hypertens Res       Date:  2020-05-18       Impact factor: 3.872

Review 2.  Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients.

Authors:  Mayumi Asai; Sei Kumakura; Mami Kikuchi
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

3.  Effects and Safety of an Oral Adsorbent on Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis.

Authors:  Ying-Chun Chen; Mei-Yi Wu; Ping-Jen Hu; Tzu-Ting Chen; Wan-Chen Shen; Wei-Chiao Chang; Mai-Szu Wu
Journal:  J Clin Med       Date:  2019-10-17       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.